Revised SPC: Equasym XL (methylphenidate) Capsules

SPC details data from use in pregnancy from a cohort study in 3,400 patients which found a small increased risk of congenital cardiac malformations. It advises that treatment is not recommended during pregnancy unless postponing treatment may pose a greater risk to the pregnancy.

Source:

electronic Medicines compendium